EyePoint, Inc. Common Stock (EYPT) News

Latest headlines that mention EYPT, newest first · each headline opens the original publisher

EYPT quote

Last price: $0.43
Day change: -0.39%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

EYPT headlines

latest coverage

Seeking Alpha News 1d ago

EyePoint, Inc. (EYPT) Discusses LUCIA Phase III Topline Results for DURAVYU in Wet Age-Related Macular Degeneration - Slideshow

General T2EYPT

Seeking Alpha News 3d ago

EyePoint, Inc. (EYPT) Discusses LUCIA Phase III Topline Results for DURAVYU in Wet Age-Related Macular Degeneration Prepared Remarks Transcript

General T2EYPT

Seeking Alpha News 1mo ago

EyePoint, Inc. (EYPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2EYPT

Seeking Alpha News 1mo ago

EyePoint, Inc. (EYPT) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

General T2EYPT

Seeking Alpha News 2mo ago

EyePoint, Inc. (EYPT) Discusses LUGANO Top Line Data From Phase III Wet AMD Trial for DURAVYU - Slideshow

General T2EYPT

Seeking Alpha News 2mo ago

EyePoint, Inc. (EYPT) Discusses LUGANO Top Line Data From Phase III Wet AMD Trial for DURAVYU Transcript

General T2EYPT

Investing.com 2mo ago

Eyepoint Pharmaceuticals stock hits 52-week low at $4.06

General T3EYPT

Seeking Alpha News 4mo ago

EyePoint, Inc. (EYPT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

General T2EYPT

Motley Fool 5mo ago

EyePoint (EYPT) Q1 2026 Earnings Transcript

Image source: The Motley Fool. Wednesday, May 6, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

Earnings T3EYPT

Seeking Alpha News 5mo ago

EyePoint, Inc. (EYPT) Q1 2026 Earnings Call Transcript

Earnings T2EYPT

EYPT news alerts

Get an alert by email or push when a new headline mentions EYPT.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.